Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis
rhGH Effects on Intermediate Outcomes in Controlled Trials: Anthropometrics
This slide presents the summary effects for anthropometric outcomes that showed improvements in rhGH-treated patients with CF when compared with untreated patients and that were classified as being of moderate- or low-level evidence quality.
Keywords: BMI | CF | HGH | LBM | anthropometrics | body mass index | bone mineral content | cystic fibrosis | height | height Z-score | height velocity | human growth hormone | lean body mass | percent ideal body weight | recombinant human growth hormone | rhGH | weight | weight Z-score | weight velocity
- Phung OJ, Coleman CI, Baker EL, et al. Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients With Cystic Fibrosis. AHRQ Comparative Effectiveness Review No. 23 (Prepared by University of Connecticut-Hartford Hospital Evidence-based Practice Center under Contract No. 290-2007-10067-I). Rockville, MD: Agency for Healthcare Research and Quality; October 2010. AHRQ Publication No. 11-EHC003-EF.
Your slide tray is being processed.